JNJ | tickerfilter.com

Fundamental analysis

55%

Profitability 63%

Dept financing 36%

Liquidity 71%

Performance 46%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0.52%

1 Month

6.76%

3 Months

13.67%

6 Months

1.13%

1 Year

3.39%

2 Year

8.91%

Key data

Stock price

$166.69

P/E Ratio

24.83

DAY RANGE

$164.70 - $168.46

EPS

$5.84

52 WEEK RANGE

$140.68 - $169.99

52 WEEK CHANGE

$2.43

MARKET CAP

349.226 B

YIELD

3.39%

SHARES OUTSTANDING

2.407 B

DIVIDEND

$1.24

EX-DIVIDEND DATE

02-18-2025

NEXT EARNINGS DATE

N/A

BETA

0.05

PUBLIC FLOAT

AVERAGE 10 VOLUME

$9,522,391

AVERAGE 30 VOLUME

$9,404,559

Company detail

CEO: Joaquin Duato
Region: US
Website: jnj.com
Employees: 152,700
IPO year: 1970

Issue type: Common Stock
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands. Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis. MedTech segment provides electrophysiology products to treat cardiovascular diseases.

JNJ - JOHNSON & JOHNSON